Structural Heart

Structural heart procedures continue to expand rapidly as minimally invasive therapies replace traditional open-heart surgery for an increasing range of cardiac conditions. Applications including transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), and left atrial appendage (LAA) occlusion require large-bore delivery systems capable of combining flexibility, stability, and highly controlled deployment.

‍

Meddux supports structural heart catheter development through advanced TAVR/TMVR/TTVR delivery catheter systems and other catheter-based technologies designed for demanding structural heart procedures. Engineering teams apply expertise in steerable catheter construction, precision shaft reinforcement, hypotube design, and integrated device technologies to create platforms optimized for navigation, deployment accuracy, manufacturability, and scalable production.

‍

From LAA occlusion device development to next-generation structural heart therapies, every program is engineered to meet the performance requirements of complex cardiac interventions.